Jeffrey Chodakewitz, EVP GMDA, CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 60,000 shares at $142.38 ($8.7M) on 2017-10-31, disclosed to the SEC on 2017-10-31.
Open-market sale of $8.7M VRTX by EVP GMDA, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.38 | 1,400 | $199K | 2.3% |
| 2 | $143.46 | 4,100 | $588K | 6.8% |
| 3 | $144.46 | 25,784 | $3.7M | 42.8% |
| 4 | $145.26 | 19,016 | $2.8M | 31.7% |
| 5 | $146.52 | 4,700 | $689K | 7.9% |
| 6 | $147.75 | 3,400 |
| $502K |
| 5.8% |
| 7 | $148.40 | 1,400 | $208K | 2.4% |
| 8 | $149.34 | 200 | $30K | 0.3% |
| Total | $145.05 avg | 60,000 | $8.7M | 100% |
| Filing → |
| VRTX | SELL | 2018-02-05 | $782K | — | Filing → |
| VRTX | SELL | 2018-01-17 | $351K | — | Filing → |
| VRTX | SELL | 2018-01-03 | $756K | — | Filing → |